《大行報告》匯豐研究升理想-W(02015.HK)目標價至219元 競爭加劇下銷售強勁
匯豐研究發表報告指,8月中旬以來理想汽車-W(02015.HK)(LI.US)的美股及港股股價分別累跌14%和18%,表現跑輸大市,主要來自投資者對電動汽車邊際折扣增加及競爭壓力的擔憂加劇。
惟該行指出,相關負面影響很大程度已反映在股價表現上,今年第三季公司生產樽頸得以消除,同時在市場競爭加劇下理想汽車的銷售仍然保持強勁,11月份銷量達到41,030輛,按年增長173%,創歷史新高,預計在強勁的產品周期支持下,未來12個月的增長可以持續。
匯豐研究將理想2023至2025年收入預測上調3%、7%及22%,淨利潤預測相應上調133%、54%及41%,看好其產品周期更加明確,維持H股「買入」評級,H股目標價由213元升至219元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.